Literature DB >> 33005621

Sebaceoma of a Meibomian Gland of the Upper Eyelid.

Frederick A Jakobiec1, Paula Cortes Barrantes1, Tatyana Milman2, Michael Yoon3.   

Abstract

Over a period of 1 year, a 74-year-old man slowly developed a painless left upper eyelid intratarsal mass. The skin was movable over the lesion. At surgery, a well-circumscribed, yellow-white, partially cystic tumor was encountered. Histopathologically it was composed of a random mixture of basaloid and sebaceous cells arranged in interconnecting cords. Immunohistochemical evaluation disclosed epithelial membrane antigen, adipophilin, and cytokeratin 14 positivity. These findings led to the diagnosis of a sebaceoma. The tumor cells abnormally failed to express mismatch repair proteins for MLH1 and PMS2. The patient did not have a personal history of any visceral malignancy, but his father had died at the age of 46 years and a daughter at the age of 33 years from colonic carcinomas. The implications of this periocular sebaceoma for the Muir-Torre syndrome are explored.
Copyright © 2020 by S. Karger AG, Basel.

Entities:  

Keywords:  Eyelid; Meibomian gland; Mismatch repair proteins; Muir-Torre syndrome; Sebaceoma; Sebaceous adenoma; Sebaceous carcinoma; Sebaceous hyperplasia

Year:  2020        PMID: 33005621      PMCID: PMC7506298          DOI: 10.1159/000504627

Source DB:  PubMed          Journal:  Ocul Oncol Pathol        ISSN: 2296-4657


  25 in total

1.  Muir-Torre syndrome: Facts and controversies.

Authors:  Christine J Ko
Journal:  Clin Dermatol       Date:  2010 May-Jun       Impact factor: 3.541

2.  Sebaceoma of the eyelid.

Authors:  Yoshihiro Yonekawa; Frederick A Jakobiec; Fouad R Zakka; Aaron Fay
Journal:  Ophthalmology       Date:  2012-12       Impact factor: 12.079

3.  Sebaceous adenoma of the eyelid and visceral malignancy.

Authors:  F A Jakobiec
Journal:  Am J Ophthalmol       Date:  1974-12       Impact factor: 5.258

4.  Sebaceous Neoplasms With Rippled, Labyrinthine/Sinusoidal, Petaloid, and Carcinoid-Like Patterns: A Study of 57 Cases Validating Their Occurrence as a Morphological Spectrum and Showing No Significant Association With Muir-Torre Syndrome or DNA Mismatch Repair Protein Deficiency.

Authors:  Katharina Wiedemeyer; Liubov Kyrpychova; Özlem Tanas Işikci; Dominic V Spagnolo; Heinz Kutzner; Arno Rütten; Maria T Fernandez-Figueras; Natalja Denisjuk; Saul Suster; Michal Pavlovsky; Fredrik Petersson; Michal Michal; Joyce Lee; Katrin Kerl; Dmitry V Kazakov
Journal:  Am J Dermatopathol       Date:  2018-07       Impact factor: 1.533

Review 5.  The molecular genetics of eyelid tumors: recent advances and future directions.

Authors:  Tatyana Milman; Steven A McCormick
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-12-30       Impact factor: 3.117

6.  Sebaceous neoplasms and the immunoprofile of mismatch-repair proteins as a screening target for syndromic cases.

Authors:  Marie Boennelycke; Birthe M Thomsen; Susanne Holck
Journal:  Pathol Res Pract       Date:  2014-10-23       Impact factor: 3.250

7.  Ocular Adnexal Adenomatoid Sebaceous Gland Hyperplasia: A Clinical and Immunopathologic Analysis in Relation to the Muir-Torre Syndrome.

Authors:  Frederick A Jakobiec; Paula Cortes Barrantes; Tatyana Milman; Nahyoung Grace Lee; Aaron Fay
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2020 Jan/Feb       Impact factor: 1.746

8.  Diagnostic utility of adipophilin immunostain in periocular carcinomas.

Authors:  Tatyana Milman; Matthew J Schear; Ralph C Eagle
Journal:  Ophthalmology       Date:  2013-11-28       Impact factor: 12.079

Review 9.  Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer.

Authors:  John M Carethers; Elena M Stoffel
Journal:  World J Gastroenterol       Date:  2015-08-21       Impact factor: 5.742

10.  Unusual eyelid tumors with sebaceous differentiation in the Muir-Torre syndrome. Rapid clinical regrowth and frank squamous transformation after biopsy.

Authors:  F A Jakobiec; L E Zimmerman; F La Piana; A Hornblass; R A Breffeilh; J K Lackey
Journal:  Ophthalmology       Date:  1988-11       Impact factor: 12.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.